Literature DB >> 15698996

[Expressions of Abeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats].

Wen-Zheng Chu1, Cai-Yun Qian.   

Abstract

OBJECTIVE: To investigate the effects of intracerebroventricular (ICV) administration of streptozotocin (STZ) on the expressions of Abeta and hyperphosphorylation of tau protein in rat brain.
METHODS: Twenty-four adult SD rats were randomized into 2 groups to receive ICV of STZ bilaterally at the dose of 3 mg/kg (with the injection repeated on day 3) or normal saline injection in an identical manner. Twenty-one days later, the expressions of Abeta(1-40), Abeta(1-42), tau(202), tau(396) and tau(404) were investigated immunohistochemically.
RESULTS: After STZ administration, the expressions of Abeta(1-40), Abeta(1-42), tau(202), tau(396) and tau(404) increased in both the cortex and hippocampus in the rat brain.
CONCLUSION: ICV injection of STZ increases the expression of Abeta and promotes hyerphosphorylation of tau protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698996

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  9 in total

Review 1.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

2.  Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

Authors:  Mohsen Khalili; Faezeh Hamzeh
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

Review 3.  Recent rodent models for Alzheimer's disease: clinical implications and basic research.

Authors:  Nady Braidy; Pablo Muñoz; Adrian G Palacios; Gloria Castellano-Gonzalez; Nibaldo C Inestrosa; Roger S Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  J Neural Transm (Vienna)       Date:  2011-11-16       Impact factor: 3.575

4.  Determination of the Best Concentration of Streptozotocin to Create a Diabetic Brain Using Histological Techniques.

Authors:  Marzieh Dehghan-Shasaltaneh; Nasser Naghdi; Samira Choopani; Leila Alizadeh; Bahram Bolouri; Ali Masoudi-Nejad; Gholam Hossein Riazi
Journal:  J Mol Neurosci       Date:  2016-01-20       Impact factor: 3.444

5.  Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi.

Authors:  Lai-Ling Du; Jia-Zhao Xie; Xiang-Shu Cheng; Xiao-Hong Li; Fan-Li Kong; Xia Jiang; Zhi-Wei Ma; Jian-Zhi Wang; Chen Chen; Xin-Wen Zhou
Journal:  Age (Dordr)       Date:  2013-10-20

6.  Mitochondrial protective and anti-apoptotic effects of Rhodiola crenulata extract on hippocampal neurons in a rat model of Alzheimer's disease.

Authors:  Jun-Mei Wang; Ze-Qiang Qu; Jin-Lang Wu; Peter Chung; Yuan-Shan Zeng
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

7.  Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer's disease.

Authors:  Matin Ramezani; Niloufar Darbandi; Fariba Khodagholi; Azam Hashemi
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

8.  Shenzhiling oral solution promotes myelin repair through PI3K/Akt-mTOR pathway in STZ-induced SAD mice.

Authors:  Gaofeng Qin; Yahan Wang; Zhenhong Liu; Lulu Mana; Shuaiyang Huang; Pengwen Wang
Journal:  3 Biotech       Date:  2021-07-01       Impact factor: 2.893

Review 9.  Insulin dysfunction and Tau pathology.

Authors:  Noura B El Khoury; Maud Gratuze; Marie-Amélie Papon; Alexis Bretteville; Emmanuel Planel
Journal:  Front Cell Neurosci       Date:  2014-02-11       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.